BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 23841723)

  • 1. Influence of protein corona on the transport of molecules into cells by mesoporous silica nanoparticles.
    Paula AJ; Araujo Júnior RT; Martinez DS; Paredes-Gamero EJ; Nader HB; Durán N; Justo GZ; Alves OL
    ACS Appl Mater Interfaces; 2013 Sep; 5(17):8387-93. PubMed ID: 23841723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surfactant-assisted controlled release of hydrophobic drugs using anionic surfactant templated mesoporous silica nanoparticles.
    Tsai CH; Vivero-Escoto JL; Slowing II; Fang IJ; Trewyn BG; Lin VS
    Biomaterials; 2011 Sep; 32(26):6234-44. PubMed ID: 21684000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs.
    Jia L; Shen J; Li Z; Zhang D; Zhang Q; Duan C; Liu G; Zheng D; Liu Y; Tian X
    Int J Pharm; 2012 Dec; 439(1-2):81-91. PubMed ID: 23078857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topography-driven bionano-interactions on colloidal silica nanoparticles.
    Paula AJ; Silveira CP; Martinez DS; Souza Filho AG; Romero FV; Fonseca LC; Tasic L; Alves OL; Durán N
    ACS Appl Mater Interfaces; 2014 Mar; 6(5):3437-47. PubMed ID: 24524580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
    Yan Y; Fu J; Wang T; Lu X
    Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The packaging of siRNA within the mesoporous structure of silica nanoparticles.
    Li X; Xie QR; Zhang J; Xia W; Gu H
    Biomaterials; 2011 Dec; 32(35):9546-56. PubMed ID: 21906804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic Fe3O4@mesoporous silica composites for drug delivery and bioadsorption.
    Huang S; Li C; Cheng Z; Fan Y; Yang P; Zhang C; Yang K; Lin J
    J Colloid Interface Sci; 2012 Jun; 376(1):312-21. PubMed ID: 22444483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesoporous silica nanoparticles capped with disulfide-linked PEG gatekeepers for glutathione-mediated controlled release.
    Cui Y; Dong H; Cai X; Wang D; Li Y
    ACS Appl Mater Interfaces; 2012 Jun; 4(6):3177-83. PubMed ID: 22646097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers.
    Popat A; Hartono SB; Stahr F; Liu J; Qiao SZ; Qing Max Lu G
    Nanoscale; 2011 Jul; 3(7):2801-18. PubMed ID: 21547299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amidase-responsive controlled release of antitumoral drug into intracellular media using gluconamide-capped mesoporous silica nanoparticles.
    Candel I; Aznar E; Mondragón L; de la Torre C; Martínez-Máñez R; Sancenón F; Marcos MD; Amorós P; Guillem C; Pérez-Payá E; Costero A; Gil S; Parra M
    Nanoscale; 2012 Nov; 4(22):7237-45. PubMed ID: 23072883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronic acid oligosaccharide modified redox-responsive mesoporous silica nanoparticles for targeted drug delivery.
    Zhao Q; Geng H; Wang Y; Gao Y; Huang J; Wang Y; Zhang J; Wang S
    ACS Appl Mater Interfaces; 2014 Nov; 6(22):20290-9. PubMed ID: 25311422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic field enhanced cell uptake efficiency of magnetic silica mesoporous nanoparticles.
    Liu Q; Zhang J; Xia W; Gu H
    Nanoscale; 2012 Jun; 4(11):3415-21. PubMed ID: 22543531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface functionalized mesoporous silica nanoparticles with natural proteins for reduced immunotoxicity.
    Luo Z; Hu Y; Xin R; Zhang B; Li J; Ding X; Hou Y; Yang L; Cai K
    J Biomed Mater Res A; 2014 Nov; 102(11):3781-94. PubMed ID: 24288246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid coated mesoporous silica nanoparticles as photosensitive drug carriers.
    Yang Y; Song W; Wang A; Zhu P; Fei J; Li J
    Phys Chem Chem Phys; 2010 May; 12(17):4418-22. PubMed ID: 20407714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy.
    Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A
    Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesoporous silica nanoparticles as nanocarriers.
    Wu SH; Hung Y; Mou CY
    Chem Commun (Camb); 2011 Sep; 47(36):9972-85. PubMed ID: 21716992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox-responsive mesoporous silica as carriers for controlled drug delivery: a comparative study based on silica and PEG gatekeepers.
    Wang Y; Han N; Zhao Q; Bai L; Li J; Jiang T; Wang S
    Eur J Pharm Sci; 2015 May; 72():12-20. PubMed ID: 25701727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient intracellular delivery of camptothecin by silica/titania hollow nanoparticles.
    Kim C; Kim S; Oh WK; Choi M; Jang J
    Chemistry; 2012 Apr; 18(16):4902-8. PubMed ID: 22422377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano-Bio Interactions of Porous and Nonporous Silica Nanoparticles of Varied Surface Chemistry: A Structural, Kinetic, and Thermodynamic Study of Protein Adsorption from RPMI Culture Medium.
    Lehman SE; Mudunkotuwa IA; Grassian VH; Larsen SC
    Langmuir; 2016 Jan; 32(3):731-42. PubMed ID: 26716353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncovalent Surface Locking of Mesoporous Silica Nanoparticles for Exceptionally High Hydrophobic Drug Loading and Enhanced Colloidal Stability.
    Palanikumar L; Kim HY; Oh JY; Thomas AP; Choi ES; Jeena MT; Joo SH; Ryu JH
    Biomacromolecules; 2015 Sep; 16(9):2701-14. PubMed ID: 26200587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.